中文 | English
Return
Total: 7 , 1/1
Show Home Prev Next End page: GO
MeSH:(Uterine Cervical Neoplasms/*surgery/virology)

1.Posttreatment human papillomavirus testing for residual or recurrent high-grade cervical intraepithelial neoplasia: a pooled analysis.

Mamiko ONUKI ; Koji MATSUMOTO ; Manabu SAKURAI ; Hiroyuki OCHI ; Takeo MINAGUCHI ; Toyomi SATOH ; Hiroyuki YOSHIKAWA

Journal of Gynecologic Oncology 2016;27(1):e3-

2.Low initial human papillomavirus viral load may indicate worse prognosis in patients with cervical carcinoma treated with surgery.

Ting DENG ; Yanling FENG ; Junsheng ZHENG ; Qidan HUANG ; Jihong LIU

Journal of Gynecologic Oncology 2015;26(2):111-117

3.Clinical features and treatment of cervical malignant tumor in young women.

Yu ZHANG ; Keng SHEN ; Jin-song GAO ; Ming WU ; Hui-fang HUANG ; Ling-ya PAN ; Jing-he LANG

Acta Academiae Medicinae Sinicae 2003;25(4):391-395

4.Clinical features and prognosis of cervical cancer in young women.

Lanqin CAO ; Xin LI ; Yi ZHANG ; Xinguo LI ; Qian WANG

Journal of Central South University(Medical Sciences) 2010;35(8):875-878

5.Expression of epidermal growth factor receptor and the correlation with HPV16/18 infection in cervical intraepithelial neoplasia and cervical carcinoma.

Shu-Yu FENG ; Yan-Na ZHANG ; Ji-Hong LIU ; Jian-Gang LIU ; Ming YAN

Chinese Journal of Oncology 2007;29(10):759-763

6.A human papillomavirus (HPV)-16 or HPV-18 genotype is a reliable predictor of residual disease in a subsequent hysterectomy following a loop electrosurgical excision procedure for cervical intraepithelial neoplasia 3.

Woo Dae KANG ; U Chul JU ; Seok Mo KIM

Journal of Gynecologic Oncology 2016;27(1):e2-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 7 , 1/1 Show Home Prev Next End page: GO